Connecting Patients to the drug that best fits their genetic makeup-a discipline called pharmacogenetics-is gaining in popularity, including amongst those suffering from mental illness. Recent research suggests that 2 in 3 Americans suffering from mental illness are interested in taking a genetic test to determine their best treatment plan. Read more here.
Dr. Gregory Mattingly, a practicing psychiatrist for over 25 years, offers some insight on the halting and all too commonly ineffective methods used to treat mental illness. As Dr. Mattingly explains, while the initial cost savings insurance companies derive from ‘step therapy’ are desirable, the failure to adequately treat a patient is more expensive over the long run and, most importantly, often fails to alleviate suffering in any measurable way. Read the blog here.